Detalhe da pesquisa
1.
Immunodepletion of MDSC by AMV564, a novel bivalent, bispecific CD33/CD3 T cell engager, ex vivo in MDS and melanoma.
Mol Ther
; 30(6): 2315-2326, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35150889
2.
Characterization of CD33/CD3 Tetravalent Bispecific Tandem Diabodies (TandAbs) for the Treatment of Acute Myeloid Leukemia.
Clin Cancer Res
; 22(23): 5829-5838, 2016 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-27189165